Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2025-12-25 @ 4:54 PM
NCT ID:
NCT00486603
Group ID:
EG004
Title:
Phase 2: RT+TMZ+HCQ - MTD 600mg
Description:
Daily hydroxychloroquine (HCQ) on 1st day of RT and concomitant temozolomide for 6wks during RT. Dose of HCQ is 600mg MTD. After 6 wks, 4 wkd of HCQ alone daily. this will complete 10 week cycle. -Initiation Phase
temozolomide: TMZ daily 75mg/m2 for 6wks with RT+HCQ (TMZ is given only during Initiation cycle)
pharmacological study: Seven samples in total will be collected baseline, initiation cycle -week3-4, week9-10, Maintenance Cycle 1 Week 4 (C1W4), Cycle2 Week4, Cycle3 Week4, Cycle6 Week4
Radiation: Radiation during the first six weeks of treatment Monday-Friday
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
53
Serious Number At Risk:
76
Other Number Affected:
76
Other Number At Risk:
76
Study:
NCT00486603
Results Section:
NCT00486603
Adverse Events Module:
NCT00486603